Evaluation of the prognostic significance of HMGB1 expression by Kaplan–Meier survival analysis using the GSE96058 dataset revealed the association of the increased HMGB1 expression with poorer overall survival in patients with breast cancer (Fig. 1A). This evidence concerns the gene HMGB1 and breast carcinoma.